Is C-reactive protein sufficient to guide antimicrobial therapy for lower respiratory tract infections among children? Results from a stepped-wedge cluster randomized trial in Uganda.
Saved in:
Main Authors: | Chris A Rees, Prashant Mahajan, Quique Bassat |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-09-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.1004467 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Grepafloxacin Clinical Program for Lower Respiratory Tract Infections
by: Arne C Rodloff
Published: (1998-01-01) -
The dawn of preventing respiratory syncytial virus lower respiratory tract infections in children
by: Z Dangor, et al.
Published: (2024-11-01) -
Current Antibiotic Treatment and Outcome for Lower Respiratory Tract Infections
by: Alasdair P MacGowan, et al.
Published: (1998-01-01) -
Understanding the local-level variations in seasonality of human respiratory syncytial virus infection: a systematic analysis
by: Sheng Ye, et al.
Published: (2025-01-01) -
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
by: Catherine A. Panozzo, et al.
Published: (2024-11-01)